Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography

Size: px
Start display at page:

Download "Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography"

Transcription

1 Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira Sato, Tomoya Hoshi, Seiga Sai, Yuki Kakefuda, Toru Adachi, Daigo Hiraya, Taizo Kimura, Zeng Wang, Kazutaka Aonuma

2 Presenter Disclosure Information Akira Sato, MD Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography DISCLOSURE INFORMATION: Nothing to disclose related to this presentation.

3 Background The presence of metabolic syndrome (MetS) is a strong predictor of future cardiovascular disease and death. (Lakka HM, et al. JAMA. 2002;288: ) (Koren-Morag N, et al. Stroke. 2005;36: ) However, obese individuals without the MetS, sometimes referred to as metabolically healthy obese (MHO), did not demonstrate an increased risk of cardiovascular disease. (Meigs JB, et al. J Clin Endocriol Metab. 2006;91: )

4 Background Contrast-enhanced computed tomography angiography has been proposed as an emerging tool for stenosis detection, characterization, and quantification of coronary atherosclerotic plaques. (Miller JM, et al. N Engl J Med 2008;359: ) CT characteristics of culprit lesions in acute coronary syndrome (ACS) include positive remodeling (PR), lowattenuation plaques (LAP), and spotty calcification. (Motoyama S, et al. J Am Coll Cardiol 2007;50:319 26) Patients with 2 plaque characteristics (PR and LAP) on CT angiography were at a higher risk of developing ACS than patients without these characteristics during followup. (S. Motoyama et al. J Am Coll Cardiol 2009;54:49 57)

5 Purpose We hypothesized that MetS is a risk factor for cardiovascular disease and death regardless of BMI status and that overweight/obesity without MetS is not associated with higher cardiovascular risk. The purpose of this study was to investigate the association between combinations of BMI categories and MetS and the characteristics of coronary plaques using computed tomography angiography (CTA).

6 Subjects 455 patients with suspected coronary artery disease (CAD) underwent 64-slice MDCT between April 2009 and August Normal weight (BMI <25) Overweight (25 BMI<30) 1 MetS (-) n=261 3 MetS (-) n=52 2 MetS (+) n=58 4 MetS (+) n=58 Obese (30 BMI) 5 MetS (-) n=18 6 MetS (+) n=24

7 Metabolic Syndrome Criteria The Japanese criteria require central obesity as a mandatory component. Waist circumference >85 cm in men and >90 cm in women. In addition, 2 or more of the following 3 factors are necessary: 1 Systolic blood pressure of >130 mmhg and/or diastolic blood pressure of >85 mmhg 2 Serum triglyceride level >150 mg/dl and/or serum high-density lipoprotein cholesterol level <40 mg/dl 3 Fasting glucose level >110 mg/dl

8 64-slice MDCT ~Brilliance CT 64~ CT system and devices CT system: Brilliance 64 (Philips) 3D Workstation: Brilliance Workspace (Philips) Scan protocols Contrast material injection protocols Tube voltage 120 kv Concentration 370 mgi/ml Volume 60 ml (contrast) Tube current ma 40 ml (saline) Rotation time 0.42 s Flow rate 4 ml/s Slice collimation Scan start method Bolus-tracking mm HR >70/min Metoprolol 20 mg p.o.

9 Methods Coronary plaque was visually classified as follows: 1) Calcified plaque (CP) Any structure with CT attenuation of >130 HU that could be visualized separately from the contrastenhanced coronary lumen. 2) Non-calcified plaque (NCP) Calcified tissue (-) 3) Mixed plaque (MP) Plaque with non-calcified and calcified elements present (Kitagawa T, et al. Am Heart J 2007;154: ) (Kajinami K et al. J Am Coll Cardiol 1997;29: )

10 Methods Positive remodeling (PR) Target lesion of EEM-CSA/reference EEM-CSA (the average of proximal and distal) Remodeling index (RI) >1.10 Positive remodeling (Motoyama S, et al. J Am Coll Cardiol 2007;50:319-26) Low-attenuation plaque (LAP) CT density value of <50 HU (Leber AW, et al. J Am Coll Cardiol 2004;43:1241-7) Vulnerable plaque was defined as PR (RI >1.10) and LAP (CT density value <50HU) on CT.

11 MDCT (52-year-old man, LCx) Proximal MLA Distal 16 HU Remodeling index 1.28 CT value 16 HU

12 Clinical Characteristics Normal W/O MetS (n=261) Normal With MetS (n=58) Overweight W/O MetS (n=52) Overweight With MetS (n=58) Obese W/O MetS (n=18) Obese With MetS (n=24) P value Age, years 65.5± ± ± ± ± ± Male (%) 163 (62%) 51 (88%) 26 (50%) 44 (76%) 6 (33%) 14 (58%) <0.001 BMI (kg/m²) 21.4± ± ± ± ± ±2.3 <0.01 Waist (cm) 78.7± ± ± ± ± ±8.9 <0.001 Visceral fat (cm²) 85.5± ± ± ± ± ±53.1 <0.001 Hypertension (%) 134 (51%) 49 (85%) 28 (55%) 48 (83%) 8 (44%) 21 (88%) <0.001 Diabetes (%) 87 (33%) 38 (66%) 17 (33%) 40 (69%) 2 (11%) 15 (63%) <0.001 Dyslipidemia (%) 131 (51%) 35 (60%) 29 (56%) 42 (72%) 9 (50%) 19 (79%) Smoker (%) 133 (51%) 41 (71%) 22 (42%) 35 (60%) 5 (28%) 16 (67%) Hs-CRP (mg/dl) 0.18± ± ± ± ± ±

13 Characteristics of the Coronary Plaque Detected by 64-slice CT Angiography Normal W/O MetS (n=261) Normal with MetS (n=58) Overweight W/O MetS (n=52) Overweight with MetS (n=58) Obese Obese W/O MetS With MetS (n=18) (n=24) P value Calcium score 288± ± ± ±726 84± ± MVD (%) 100 (40%) 32 (55%) 13 (27%) 25 (46%) 5 (28%) 10 (42%) No. of coronary plaques per patient 2.71± ± ± ± ± ±2.40 <0.001 >50% stenosis 1.78± ± ± ± ± ±2.20 <0.001 >50% stenosis with calcified plaque >50% stenosis with non-calcified >50% stenosis with mixed plaque 0.46± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ±1.23 <0.001

14 Mean number of plaques (n) Mean Number of Vulnerable Plaques P <0.001 P = * P <0.01 vs normal + MetS (-) * * * MetS (-) MetS (+) (n=261) (n =58) (n=52) (n =58) (n=18) (n 24) Normal <25 Overweight Body mass index (kg/m 2 ) Obese >30

15 Logistic Regression Analysis for Detection of Vulnerable Plaque BMI/MetS categories Odds ratio (95% CI) P value Normal weight Without MetS Normal weight With MetS Overweight Without MetS Overweight With MetS Obese Without MetS Obese With MetS (reference) 5.53 ( ) < ( ) ( ) < ( ) ( ) <0.001 Data are adjusted for age, smoking, and LDL-cholesterol.

16 Summary The number of vulnerable plaques per patient was significantly higher in patients with MetS and obese patients without MetS than in normal-weight patients without MetS, whereas there was no difference in these number between overweight and normal-weight patients without MetS. In multivariate logistic analysis, an association with vulnerable plaques was observed in normal-weight patients with MetS (OR 5.53), overweight patients with MetS (OR 6.31), obese patients without MetS (OR 3.43), and obese patients with MetS (OR 6.66) but not observed in overweight patients without MetS, compared with normal-weight patients without MetS.

17 Study Limitations The sample size was relatively small. We excluded patients with severely calcified lesions and motion artifact in this study. CT plaque density can be altered by the concentration of the contrast agent administered, by contrast type, or by the model of CT used.

18 Conclusion MetS and obese patients without MetS are associated with coronary vulnerable plaques, whereas overweight patients without MetS had no significant increased risk of plaque vulnerability. 64-slice MDCT allows noninvasive assessment of vulnerable plaques throughout the coronary arteries, which is necessary for optimal medical therapy to prevent cardiovascular events.

Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score

Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score ESC Congress 2011 Epicardial fat volume as a predictor of coronary vulnerable plaques using cardiac computed tomography in the patients with zero calcium score K. Harada, N. Terada, A. Okada, M. Shigekiyo,

More information

Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound

Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound Department of Cardiovascular Medicine Heart and Vascular Institute

More information

Characteristics of Subclinical Coronary Artery Disease in Diabetic Patients without Known Coronary Artery Disease

Characteristics of Subclinical Coronary Artery Disease in Diabetic Patients without Known Coronary Artery Disease IBIMA Publishing Journal of Research in Diabetes http://www.ibimapublishing.com/journals/diab/diab.html Vol. 2014 (2014), Article ID 322292, 12 pages DOI: 10.5171/2014.322292 Research Article Characteristics

More information

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million

More information

RAMA-EGAT Risk Score for Predicting Coronary Artery Disease Evaluated by 64- Slice CT Angiography

RAMA-EGAT Risk Score for Predicting Coronary Artery Disease Evaluated by 64- Slice CT Angiography RAMA-EGAT Risk Score for Predicting Coronary Artery Disease Evaluated by 64- Slice CT Angiography Supalerk Pattanaprichakul, MD 1, Sutipong Jongjirasiri, MD 2, Sukit Yamwong, MD 1, Jiraporn Laothammatas,

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,

More information

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification

Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Cardiac CT for Risk Assessment: Do we need to look beyond Coronary Artery Calcification Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA

More information

Patient referral for elective coronary angiography: challenging the current strategy

Patient referral for elective coronary angiography: challenging the current strategy Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology

More information

Yukio Ozaki, M Okumura, TF Ismail 2, S Motoyama, H. Naruse, K. Hattori, H. Kawai, M. Sarai, J. Ishii, Jagat Narula 3

Yukio Ozaki, M Okumura, TF Ismail 2, S Motoyama, H. Naruse, K. Hattori, H. Kawai, M. Sarai, J. Ishii, Jagat Narula 3 Culprit Lesion Characteristics in Acute Coronary Syndrome and Stable Angina Assessed by Optical Coherence Tomography (OCT), Angioscopy, IVUS and Multidetector Computed Tomography (MDCT) Yukio Ozaki, M

More information

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Coronary Artery Imaging Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital Larger array : cover scan area Detector size : spatial resolution Rotation speed : scan time Retrospective

More information

Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome

Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome 243 Original Article Hypertens Res Vol.30 (2007) No.3 p.243-247 Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome Yutaka KOJI

More information

CT or PET/CT for coronary artery disease

CT or PET/CT for coronary artery disease CT or PET/CT for coronary artery disease Rotterdam 2012 Juhani Knuuti, MD, PhD, FESC Turku PET Centre University of Turku Turku, Finland Juhani.knuuti@utu.fi Turku PET Centre University of Turku Åbo Akademi

More information

Jinling Zhang, 1 Zhehao Lv, 1 Deli Zhao, 1 Lili Liu, 1 Yong Wan, 1 Tingting Fan, 1 Huimin Li, 1 Ying Guan, 1 Bailu Liu, 1 and Qi Yang 2,3

Jinling Zhang, 1 Zhehao Lv, 1 Deli Zhao, 1 Lili Liu, 1 Yong Wan, 1 Tingting Fan, 1 Huimin Li, 1 Ying Guan, 1 Bailu Liu, 1 and Qi Yang 2,3 Diabetes Research Volume 2016, Article ID 4365156, 6 pages http://dx.doi.org/10.1155/2016/4365156 Research Article Coronary Plaque Characteristics Assessed by 256-Slice Coronary CT Angiography and Association

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD Sao Paulo Medical School Hospital Sao Paulo, Brazil Disclosure Honoraria received for consult and/or speaker : Astra Zeneca, Amgen,

More information

HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms

HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms Hong Lai, PhD; Richard Moore, MD; David D. Celentano, ScD; Gary

More information

MDCT による冠動脈狭窄や石灰化スコアの評価と PWV の関連性

MDCT による冠動脈狭窄や石灰化スコアの評価と PWV の関連性 Online publication May 27, 2010 総 説 第 49 回総会シンポジウム 2 血管病スクリーニングのための画像診断 MDCT による冠動脈狭窄や石灰化スコアの評価と PWV の関連性 要旨 : CT MDCT MDCT MDCT PWV J Jpn Coll Angiol, 2010, 50: 163 167 Key words: coronary artery disease,

More information

Simon Nepveu 1, Irina Boldeanu 1, Yves Provost 1, Jean Chalaoui 1, Louis-Mathieu Stevens 2,3, Nicolas Noiseux 2,3, Carl Chartrand-Lefebvre 1,3

Simon Nepveu 1, Irina Boldeanu 1, Yves Provost 1, Jean Chalaoui 1, Louis-Mathieu Stevens 2,3, Nicolas Noiseux 2,3, Carl Chartrand-Lefebvre 1,3 Coronary Artery Bypass Graft Imaging with CT Angiography and Iterative Reconstruction: Quantitave Evaluation of Radiation Dose Reduction and Image Quality Simon Nepveu 1, Irina Boldeanu 1, Yves Provost

More information

Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography

Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography Original Paper Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography Ryoko Mitsutake, MD, PhD; Shin-ichiro Miura, MD, PhD; Yuhei Shiga, MD; Yoshinari

More information

Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017

Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017 Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017 F Prati San Giovanni H. and CLI Foundation, Rome Euro Image Research Che cosa preoccupa il cardiologo

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416). Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52

More information

ZEUS Trial ezetimibe Ultrasound Study

ZEUS Trial ezetimibe Ultrasound Study Trial The lower, The better Is it True for Plaque Regression? Statin alone versus Combination of Ezetimibe and Statin Juntendo University, Department of Cardiology, Tokyo, Japan Katsumi Miyauchi, Naohisa

More information

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Cardiovascular Research Foundation and Columbia University Medical Center, New York. Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,

More information

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:

More information

Cardiac CT Angiography

Cardiac CT Angiography Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis

More information

Depok-Indonesia STEPS Survey 2003

Depok-Indonesia STEPS Survey 2003 The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural

More information

Improvement of Image Quality with ß-Blocker Premedication on ECG-Gated 16-MDCT Coronary Angiography

Improvement of Image Quality with ß-Blocker Premedication on ECG-Gated 16-MDCT Coronary Angiography 16-MDCT Coronary Angiography Shim et al. 16-MDCT Coronary Angiography Sung Shine Shim 1 Yookyung Kim Soo Mee Lim Received December 1, 2003; accepted after revision June 1, 2004. 1 All authors: Department

More information

CARDIAC IMAGING FOR SUBCLINICAL CAD

CARDIAC IMAGING FOR SUBCLINICAL CAD CARDIAC IMAGING FOR SUBCLINICAL CAD WHY DON'T YOU ADOPT MORE SMART TECHNIQUE? Whal Lee, M.D. Seoul National University Hospital Department of Radiology We are talking about Coronary artery Calcium scoring,

More information

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease 21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease Noninvasive Evaluation of Coronary Artery Disease: Anatomical, Functional, Clinical May 5, 2018 Mark Hansen MD FRCPC Cardiologist,

More information

Objective Calcium score carotid IMT hs-crp

Objective Calcium score carotid IMT hs-crp P3952 Role of coronary calcium score, carotid intima-media thickness and C-reactive protein in predicting extent of coronary artery disease in young patients. Bedside Poster P3952 Role of coronary calcium

More information

Non-invasive Imaging of Carotid Artery Atherosclerosis

Non-invasive Imaging of Carotid Artery Atherosclerosis Non-invasive Imaging of Carotid Artery Atherosclerosis 최연현 성균관의대삼성서울병원영상의학과 Noninvasive Techniques US with Doppler CT MRI Ultrasonography Techniques of Carotid US US Anatomy (ICA vs ECA) Gray scale and

More information

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li

More information

Title for Paragraph Format Slide

Title for Paragraph Format Slide Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38

More information

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O. Using Coronary Artery Calcium Score in the Quest for Cardiac Health Robert J. Hage, D.O. Heart disease is the leading cause of death in the United States in both men and women. About 610,000 people die

More information

Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study

Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study Received: 1 July 2016 Revised: 20 October 2016 Accepted: 26 October 2016 DOI 10.1002/clc.22646 CLINICAL INVESTIGATIONS Effect of treatment with 5-lipoxygenase inhibitor (atreleuton) on coronary plaque

More information

How to Reduce Residual Risk in Primary Prevention

How to Reduce Residual Risk in Primary Prevention How to Reduce Residual Risk in Primary Prevention Helene Glassberg, MD Assistant Professor of Medicine Section of Cardiology Hospital of the University of Pennsylvania Philadelphia, PA USA Patients with

More information

Metabolic Syndrome and Workplace Outcome

Metabolic Syndrome and Workplace Outcome Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist

More information

Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.

Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United

More information

DECLARATION OF CONFLICT OF INTEREST. Nothing to disclose

DECLARATION OF CONFLICT OF INTEREST. Nothing to disclose DECLARATION OF CONFLICT OF INTEREST Nothing to disclose Prognostic value of multidetector computed tomography coronary angiography in a large population of patients with unknown cardiac disease but suspected

More information

Shiftwork and cardiometabolic outcomes. Dr Anil Adisesh

Shiftwork and cardiometabolic outcomes. Dr Anil Adisesh Shiftwork and cardiometabolic outcomes Dr Anil Adisesh 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anil Adisesh Relationships with commercial interests: - None 2 Aims 1) Participants will be able to describe

More information

3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles

3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles Outline Relationships among Regional Adiposity, Physical Activity, and CVD Risk Factors: Preliminary Results from Two Epidemiologic Studies Molly Conroy, MD, MPH Obesity Journal Club February 18, 2010

More information

Oxford Technology Showcase 2016 Big Healthcare Challenges in chronic disease. Inflammation quantification for cardiovascular risk characterisation

Oxford Technology Showcase 2016 Big Healthcare Challenges in chronic disease. Inflammation quantification for cardiovascular risk characterisation Big Healthcare Challenges in chronic disease Inflammation quantification for cardiovascular risk characterisation Developing an advanced biomarker of Coronary Artery Disease using common CT imaging Dr.

More information

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017 Coronary Artery Calcification Dharmendra A. Patel, MD MPH Director, Echocardiography Laboratory Associate Program Director Cardiovascular Disease Fellowship Program Erlanger Heart and Lung Institute UT

More information

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043

More information

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,

More information

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

Potential recommendations for CT coronary angiography in athletes

Potential recommendations for CT coronary angiography in athletes Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems

More information

Noninvasive Coronary Imaging: Plaque Imaging by MDCT

Noninvasive Coronary Imaging: Plaque Imaging by MDCT Coronary Physiology & Imaging Summit 2007 Noninvasive Coronary Imaging: Plaque Imaging by MDCT Byoung Wook Choi Department of Radiology Yonsei University, Seoul, Korea Stary, H. C. et al. Circulation

More information

Methods. Background and Objectives STRADIVARIUS

Methods. Background and Objectives STRADIVARIUS STRADIVARIUS Effect of on Progression of Atherosclerosis in Patients with Abdominal Obesity and Coronary Artery Disease Steven E. Nissen MD Stephen J. Nicholls MBBS PhD, Kathy Wolski MPH, Josep Rodés-Cabau

More information

Coronary Artery Calcification

Coronary Artery Calcification Coronary Artery Calcification Julianna M. Czum, MD OBJECTIVES CORONARY ARTERY CALCIFICATION Julianna M. Czum, MD Dartmouth-Hitchcock Medical Center 1. To review the clinical significance of coronary heart

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

대한심장학회춘계학술대회 Satellite Symposium

대한심장학회춘계학술대회 Satellite Symposium 대한심장학회춘계학술대회 Satellite Symposium Coronary Plaque Regression and Compositional Changes by Lipid-Lowering Therapy: IVUS Substudy in Livalo (Pitavastatin) in Acute Myocardial Infarction Study (LAMIS) Livalo

More information

This event does not qualify for continuing medical education (CME), continuing nursing education (CNE), or continuing education (CE) credit

This event does not qualify for continuing medical education (CME), continuing nursing education (CNE), or continuing education (CE) credit Welcome to this program sponsored by AstraZeneca The educator, who is presenting on behalf of AstraZeneca, is here to provide educational information pertinent to understanding the risk of a recurrent

More information

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases

The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases The role of coronary artery calcium score on the detection of subclinical atherosclerosis in metabolic diseases Eun-Jung Rhee Department of Endocrinology and Metabolism Kangbuk Samsung Hospital Sungkyunkwan

More information

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental

More information

Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan

Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan Association between continuously elevated C-reactive protein and restenosis after percutaneous coronary intervention using drug-eluting stent in angina patients Division of Cardiovascular Medicine, Jichi

More information

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Imaging Biomarkers: utilisation for the purposes of registration EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Vascular Imaging Technologies Carotid Ultrasound-IMT IVUS-PAV QCA-% stenosis 2 ICH E

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time Multisclice CT in combination with functional imaging for CAD Prof. Juhani Knuuti, MD, FESC Turku University Hospital and University of Turku Turku, Finland MSCT and functional imaging for CAD Practical

More information

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis

More information

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging Imaging the Vulnerable Plaque David A. Dowe, MD Atlantic Medical Imaging Why is this so important? The Acute Situation Coronary disease-important Diagnosis of cardiovascular disease cost $148 billion in

More information

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? John McB. Hodgson, M.D., FSCAI Chairman, Department of Cardiology Geisinger Health System Wilkes Barre,, Pa Disclosure Information

More information

Patient is healthy with no chronic disease or significant risk factors [16%].

Patient is healthy with no chronic disease or significant risk factors [16%]. AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II

More information

Fundamentals, Techniques, Pitfalls, and Limitations of MDCT Interpretation and Measurement

Fundamentals, Techniques, Pitfalls, and Limitations of MDCT Interpretation and Measurement Fundamentals, Techniques, Pitfalls, and Limitations of MDCT Interpretation and Measurement 3 rd Annual Imaging & Physiology Summit November 20-21, 21, 2009 Seoul, Korea Wm. Guy Weigold, MD, FACC Cardiovascular

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±

More information

M Marwan, D Ropers, T Pflederer, W G Daniel, S Achenbach

M Marwan, D Ropers, T Pflederer, W G Daniel, S Achenbach Department of Cardiology, University of Erlangen, Erlangen, Germany Correspondence to: Dr M Marwan, Innere Medizin II, Ulmenweg 18, 91054 Erlangen, Germany; mohamed.marwan@ uk-erlangen.de Accepted 17 November

More information

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

Epidemiologic Measure of Association

Epidemiologic Measure of Association Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2

More information

Radiation Dose Reduction and Coronary Assessability of Prospective Electrocardiogram-Gated Computed Tomography Coronary Angiography

Radiation Dose Reduction and Coronary Assessability of Prospective Electrocardiogram-Gated Computed Tomography Coronary Angiography Journal of the American College of Cardiology Vol. 52, No. 18, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.07.048

More information

Chapter 4. Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. Department of Radiology,

Chapter 4. Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands. Department of Radiology, Chapter 4 Impact of Coronary Calcium Score on Diagnostic Accuracy of Multislice Computed Tomography Coronary Angiography for Detection of Coronary Artery Disease Gabija Pundziute, 1,3 Joanne D. Schuijf,

More information

A new method for radiation dose reduction at cardiac CT with multi-phase data-averaging and non-rigid image registration: preliminary clinical trial

A new method for radiation dose reduction at cardiac CT with multi-phase data-averaging and non-rigid image registration: preliminary clinical trial A new method for radiation dose reduction at cardiac CT with multi-phase data-averaging and non-rigid image registration: preliminary clinical trial Poster No.: C-0595 Congress: ECR 2013 Type: Authors:

More information

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants Aggregate Report Fasting Biometric Screening CLIENTXXXX May 2, 2014 21,000 participants Contact:404.636.9437~Website:www.atlantahealthsys.com RISK FACTOR QUESTIONNAIRE Participants Percent Do not exercise

More information

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2

More information

Biomed Environ Sci, 2016; 29(3): LI Jian Hong, WANG Li Min, LI Yi Chong, ZHANG Mei, and WANG Lin Hong #

Biomed Environ Sci, 2016; 29(3): LI Jian Hong, WANG Li Min, LI Yi Chong, ZHANG Mei, and WANG Lin Hong # Biomed Environ Sci, 2016; 29(3): 205-211 205 Letter to the Editor Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Disease in Women in China: Surveillance Efforts LI Jian Hong, WANG Li

More information

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health

More information

Assessment of Non-Calcified Coronary Plaques Using 64-Slice Computed Tomography: Comparison With Intravascular Ultrasound

Assessment of Non-Calcified Coronary Plaques Using 64-Slice Computed Tomography: Comparison With Intravascular Ultrasound ORIGINAL ARTICLE DOI 10.4070 / kcj.2009.39.3.95 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Assessment of Non-Calcified Coronary Plaques Using 64-Slice

More information

Overweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes

Overweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes Overweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes Gordon L Jensen, MD, PhD Senior Associate Dean for Research Professor of Medicine and Nutrition Objectives Health outcomes

More information

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016 Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October

More information

Investigating the Frequency of Atherosclerosis Risk Factors in Patients Suffering from X Syndrome

Investigating the Frequency of Atherosclerosis Risk Factors in Patients Suffering from X Syndrome Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2016, 5, 10:84-90 Investigating the Frequency of Atherosclerosis Risk Factors in Patients

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Can We Identify Vulnerable Patients & Vulnerable Plaque?

Can We Identify Vulnerable Patients & Vulnerable Plaque? Can We Identify Vulnerable Patients & Vulnerable Plaque? We Know Enough to Treat High-Risk Lesions? Takashi Akasaka, MD, PhD Department of Cardiovascular Medicine, Japan Disclosure Statement of Financial

More information

Heart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system

Heart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system LEARN Learn about HTHU Level 3 and the point system 01 IDENTIFY Identify the major risk factors for cardiovascular disease and how to improve our cardiovascular health 03 02 ACT Begin our Session 1 Goal

More information

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool Vulnerable Plaque features on coronary CT Jin Ho Choi, MD, PhD Department of Internal Medicine, Emergency Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea IPS /

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Women and Heart Disease

Women and Heart Disease Women and Heart Disease The Very Latest in Cardiovascular Medicine and Surgery Gretchen L. Wells, MD, PhD, FACC Thomas Whayne Endowed Professor in Women s Heart Health Gill Heart Institute University of

More information

CT Coronary Angiography - Indications: From the guidelines to clinical practice

CT Coronary Angiography - Indications: From the guidelines to clinical practice CT Coronary Angiography - Indications: From the guidelines to clinical practice Multimodality Working Group of Cardiovascular Imaging (Nuc C, CCT CMR) Hellenic Cardiology Society Seminars, Thessaloniki,

More information

Computer Aided Detection and Diagnosis: Cardiac Imaging Applications

Computer Aided Detection and Diagnosis: Cardiac Imaging Applications Computer Aided Detection and Diagnosis: Cardiac Imaging Applications U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging Disclosures

More information